The ASCI report says there is ample evidence of “market dominance” in specific media markets, but the government has ignored the report for three years. A ministry official tells PARANJOY GUHA THAKURTA that it is unlikely to be implemented. A report prepared by an independent institution recommending imposition of cross-media ownership restrictions recently entered the public domain nearly three years after it was submitted,  following a rebuke to the government by...

-Live Mint It turns out that some state officials were using NRHM to enrich themselves The National Rural Health Mission (NRHM) was launched seven years ago with the goal of improving healthcare delivery to people in villages, especially the poor, through a generous infusion of federal funds. Local authorities were given a relatively free hand in deciding how to spend the money, with the Centre promising funds with no strings attached for...

Lack of knowledge, fear of political criticism are some of the reasons that are stopping FCI, according to experts What is stopping Food Corp. of India Ltd (FCI) from selling its ample wheat stocks in the open market and buying futures contracts to meet its distribution commitments in the months ahead? Or, for that matter, what is keeping the food procurement agency from selling grain futures internationally, knowing that a bumper crop...

-The Economic Times, The Cabinet has cleared a proposed Bill empowering the Reserve Bank of India (RBI) to regulate all microfinance institutions (MFIs). A central legislation makes sense only to the extent that it over-rides draconian state-level laws. However, the Bill suffers from many infirmities. And it is unfortunate that these have been overlooked. The law, if enacted, is likely to kill small MFIs and hurt the sector that is struggling...

Having watched from the ringside for many years now, I have no doubt in advising that the steering wheel must be firmly grasped by the government and direction given to policies that should be stable for at least the medium term. This is crucial for the growth of Indian pharma, a $20-billion industry growing at an average of 12% considering both domestic and export arenas. Price control: The biggest and most...